Skip to content
Screener

Sionna Therapeutics SION Enterprise value

Enterprise value at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$120.2B+7.2%
AbbVie logo
AbbVieABBV
$460.96B+24.7%
Achieve Life Sciences logo
Achieve Life SciencesACHV
$134.08M+65.7%
Septerna, Inc. logo
Septerna, Inc.SEPN
$1.45B+363%
RFL
Rafael Holdings, Inc.RFL
$52.06M+46.1%
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
$423.34M+961%

Other financials

Income statement

See full
Operating income-$29.6M-50.6%
Net income-$26.8M-62.5%
EPS (diluted)-$0.60+3.2%

Balance sheet

See full
Cash & equivalents$64.3M-23.2%
Total debt$8.4M-11.8%
Total equity$288.2M-18.1%
Total assets$305.0M-17.5%

Cash flow

See full
Operating cash flow-$21.8M-34.1%
CapEx--100%
Free cash flow-$21.8M-33.4%

Valuation

See full
Market cap$203.46M-77.0%

Returns & leverage

See full
Return on equity-26.7%—
Debt / equity0×0.0×
Current ratio22.6×-6.1×

Where this comes from

Calculated from Sionna Therapeutics’s reported figures.

$1.8Bmarket cap+$8.4Mtotal debt−$64.3Mcash and equivalents=$1.75B

The source filing: Sionna Therapeutics’s 10-Q, filed May 12, 2026. Open the filing →

Filed
May 12, 2026, 7:17 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-033876

FAQ

What is Sionna Therapeutics's enterprise value?
Sionna Therapeutics (SION) reported enterprise value of $1.75B in Q1 2026.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.

Ask your AI about Sionna Therapeutics's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude